Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification of Antithrombin-Modulating Genes. Role of LARGE, a Gene Encoding a Bifunctional Glycosyltransferase, in the Secretion of Proteins?

  • de la Morena-Barrio, María Eugenia
  • Buil, Alfonso|||0000-0002-3097-1014
  • Antón, Ana Isabel
  • Martínez-Martínez, Irene
  • Miñano, Antonia
  • Gutiérrez-Gallego, Ricardo
  • Navarro-Fernández, José
  • Aguila, Sonia
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Vicente, Vicente
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Corral de la Calle, Javier
The haemostatic relevance of antithrombin together with the low genetic variability of SERPINC1, and the high heritability of plasma levels encourage the search for modulating genes. We used a hypothesis-free approach to identify these genes, evaluating associations between plasma antithrombin and 307,984 polymorphisms in the GAIT study (352 individuals from 21 Spanish families). Despite no SNP reaching the genome wide significance threshold, we verified milder positive associations in 307 blood donors from a different cohort. This validation study suggested LARGE, a gene encoding a protein with xylosyltransferase and glucuronyltransferase activities that forms heparin-like linear polysaccharides, as a potential modulator of antithrombin based on the significant association of one SNPs, rs762057, with anti-FXa activity, particularly after adjustment for age, sex and SERPINC1 rs2227589 genotype, all factors influencing antithrombin levels (p = 0.02). Additional results sustained this association. LARGE silencing inHepG2 and HEK-EBNA cells did not affect SERPINC1 mRNA levels but significantly reduced the secretion of antithrombin with moderate intracellular retention. Milder effects were observed on α1-antitrypsin, prothrombin and transferrin. Our study suggests LARGE as the first known modifier of plasma antithrombin, and proposes a new role for LARGE in modulating extracellular secretion of certain glycoproteins. © 2013 de la Morena-Barrio et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Decreased pre-surgical CD34 +/CD144 + cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients

  • Redondo, Santiago
  • González-Rocafort, Álvaro
  • Navarro-Dorado, Jorge
  • Ramajo, Marta
  • Hristov, Mihail
  • Gordillo-Moscoso, Antonio
  • Reguillo, Fernando
  • Carnero-Alcázar, Manuel|||0000-0001-5045-5765
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Enrique
  • Weber, Christian
  • Tejerina, Teresa
Background: Cardiovascular disease has been linked to endothelial progenitor cell (EPC) depletion and functional impairment in atherosclerosis and aortic stenosis. EPCs may play a pivotal role in vascular grafting. However, the EPC depletion in coronary artery bypass grafting (CABG) patients has not been compared to coronary artery disease-free valvular replacement patients with aortic stenosis.Methods: We aimed to assess the basal number of CD34 /KDR and CD34 /CD144 cells in CABG patients, compared to aortic stenosis valvular replacement patients. 100 patients (51 CABG and 49 valvular surgery ones) were included in the present study. All CABG or valvular patients had angiographic demonstration of the presence or the absence of coronary artery disease, respectively. Numbers of CD34 /KDR and CD34 /CD144 were assessed by flow cytometry of pre-surgical blood samples.Results: We found a lower number of CD34 /CD144 cells in CABG patients compared to valvular patients (0.21 ± 0.03% vs. 0.47 ± 0.08%), and this difference remained statistically significant after the P was adjusted for multiple comparisons (P = 0.01428). Both groups had more EPCs than healthy controls.Conclusions: Pre-surgical CD34 /CD144 numbers are decreased in CABG patients, compared to valvular patients with absence of coronary disease. © 2012 Redondo et al; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Emerging therapeutic strategies to enhance HDL function

  • Redondo, Santiago
  • Martínez-González, José|||0000-0002-3894-7166
  • Urraca, C.
  • Tejerina, T.
Abstract. Epidemiologic studies indicate a strong inverse correlation between plasma levels of high-density lipoproteins (HDL) and cardiovascular disease (CVD). The most relevant cardioprotective mechanism mediated by HDL is thought to be reverse cholesterol transport (RCT). New insights in HDL biology and RCT have allowed the development of promising agents aimed to increase HDL function and promote atherosclerosis regression. In this regard, apo-AI analogs and CETP inhibitors dalcetrapib and anacetrapib have aroused a great interest and opened new expectations in the treatment of CVD. © 2011 Redondo et al; licensee BioMed Central Ltd.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Imaging of plasmacytoid dendritic cell interactions with T cells

  • Mittelbrunn, María
  • Martínez del Hoyo, Gloria
  • López-Bravo, María
  • Martín-Cofreces, Noa B
  • Scholer, Alix
  • Hugues, Stéphanie
  • Fetler, Luc
  • Amigorena, Sebastián
  • Ardavín, Carlos
  • Sánchez-Madrid, Francisco
Plasmacytoid dendritic cells (pDCs) efficiently produce type I interferon and participate in adaptive immune responses, although the molecular interactions between pDCs and antigen-specific T cells remain unknown. This study examines immune synapse (IS) formation between murine pDCs and CD4(+) T cells. Mature pDCs formed canonical ISs, involving relocation to the contact site of the microtubule-organizing center, F-actin, protein kinase C-, and pVav, and activation of early signaling molecules in T cells. However, immature pDCs were less efficient at forming conjugates with T cells and inducing IS formation, microtubule-organizing center translocation, and T-cell signaling and activation. Time-lapse videomicroscopy and 2-photon in vivo imaging of pDC-T-cell interactions revealed that immature pDCs preferentially mediated transient interactions, whereas mature pDCs promoted more stable contacts. Our data indicate that, under steady-state conditions, pDCs preferentially establish transient contacts with naive T cells and show a very modest immunogenic capability, whereas on maturation, pDCs are able to form long-lived contacts with T cells and significantly enhance their capacity to activate these lymphocytes., This work was supported by grants BFU2005-08435/BMC from the Ministerio de Educación y Ciencia, Ayuda a la Investigación Básica 2002 from Juan March Foundation and European Network MAIN LSHG-CT-2003-502935 and Red Temática de Investigación cooperativa en Enfermedades Cardiovasculares RD06/0014-0030 (F.S.-M.). G.M.d.H. was supported by Instituto de Salud Carlos III. Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Health and Consumer Affairs and the Pro-Centro Nacional de Investigaciones Cardiovasculares Foundation., Peer reviewed
Docta Complutense
Publication Artículo científico (JournalArticle)

Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin

  • Xavier, Fabiano
  • Aras López, Rosa
  • Arroyo Villa, Irene
  • Del Campo Milán, Lara
  • Salaices, Mercedes
  • Rossoni, Luciana
  • Ferrer, Mercedes
  • Balfagón, Gloria
Background and purpose: The present study was designed to assess whether cyclooxygenase-2 (COX-2) activation is involved in the effects of chronic aldosterone treatment on endothelial function of mesenteric resistance arteries (MRA) from Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR). Experimental approach: Relaxation to acetylcholine was measured in MRA from both untreated and aldosterone-treated strains. Vasomotor responses to prostacyclin and U46619 were also analysed. Release of 6-oxo-prostaglandin (PG)F1alpha and thromboxane B2 (TxB2) was determined by enzyme immunoassay. COX-2 protein expression was measured by western blot. Key results: Aldosterone reduced acetylcholine relaxation in MRA from both strains. In MRA from both aldosterone-treated strains the COX-1/2 or COX-2 inhibitor (indomethacin and NS-398, respectively), TxA2 synthesis inhibitor (furegrelate), prostacyclin synthesis inhibitor (tranylcypromine) or TxA2/ PGH2 receptor antagonist (SQ 29 548), but not COX-1 inhibitor SC-560, increased acetylcholine relaxation. In untreated rats this response was increased only in SHR. Prostacyclin elicited a biphasic vasomotor response: lower concentrations elicited relaxation, whereas higher concentrations elicited contraction that was reduced by SQ 29 548. Aldosterone increased the acetylcholine-stimulated production of 6-oxo-PGF(1alpha) and TxB2 in MRA from both strains. COX-2 expression was higher in both strains of rats treated with aldosterone. Conclusions and implications: Chronic treatment with aldosterone impaired endothelial function in MRA under normotensive and hypertensive conditions by increasing COX-2-derived prostacyclin and thromboxane A2. As endothelial dysfunction participates in the pathogenesis of many cardiovascular disorders we hypothesize that anti-inflammatory drugs, specifically COX-2 inhibitors, could ameliorate vascular damage in patients with elevated aldosterone production.